Which drug inhibits mevalonic acid pathway?

Statins are antidyslipidemic drugs that inhibit hydroxymethylglutaryl coenzyme A (HMG-CoA) reductase in the upstream part of the mevalonate pathway and reduce cholesterol levels in blood [5].

What drugs inhibit mevalonate?

Pitavastatin inhibits HMGCR, reducing the supply of mevalonate that is used to synthesize isoprenoids and zoledronic acid is known to inhibit farnesyl diphosphate synthase37,38,39,40 which is also part of the mevalonate pathway.

What is the mevalonate pathway responsible for?

production of cholesterol
The function of the mevalonate pathway is the production of cholesterol as well as the synthesis of isoprenoid lipids such as farnesyl diphosphate (FPP) and geranylgeranyl diphosphate (GGPP).

How is mevalonate pathway regulated?

The MVA biosynthetic pathway is regulated by transcriptional and post-transcriptional mechanisms including modulation of gene transcription, mRNA translation, protein degradation, and enzymatic activity (44, 49).

What reaction is involved in the conversion of mevalonate to isopentenyl pyrophosphate?

The conversion of mevalonic acid to isopentenyl 5-diphosphate involves three ATP-dependent phosphorylation reactions.

What is end result of mevalonate pathway?

The first step in cholesterol biosynthesis is the generation of a 3-hydroxy-3-methyl-glutaryl CoA (HMG-COA) from acetyl-CoA units.

Where does mevalonate pathway run in the cell?

Alternative pathway Interaction between the two metabolic pathways can be studied by using 13C-glucose isotopomers. In higher plants, the MEP pathway operates in plastids while the mevalonate pathway operates in the cytosol.

How is mevalonate produced?

Upper mevalonate pathway The first step condenses two acetyl-CoA molecules to yield acetoacetyl-CoA. This is followed by a second condensation to form HMG-CoA (3-hydroxy-3- methyl-glutaryl-CoA). Reduction of HMG-CoA yields (R)-mevalonate. These first 3 enzymatic steps are called the upper mevalonate pathway.

How do statins inhibit HMG-CoA reductase?

Statins competitively inhibit the HMG-CoA reductase enzyme. Statins bind to the active site of the enzyme and change its structure. As the structure of the enzyme is changed, it cannot bind with the receptor, thus its activity is reduced.

What is the precursor of mevalonate pathway?

Isoprenoid precursors DMAPP and IPP are naturally produced in the cell through one of two pathways (2). The mevalonate (MVA) pathway involves seven reactions to produce IPP from acetyl-CoA. DMAPP is then produced through the isomerization of IPP by the enzyme isopentenyl-pyrophosphate delta isomerase (IDI).

Is mevalonate a cholesterol?

Cholesterol is synthesized via a cascade of enzymatic reactions known as the mevalonate pathway. This series of reactions is primarily regulated by a rate-limiting step involving the conversion of hydroxyl-methyl glutaryl-coenzyme A (HMG-CoA) into mevalonate.

Which drug is a HMG-CoA reductase inhibitor?

Pitavastatin (Livalo) HMG-CoA reductase inhibitor (statin) indicated for primary or mixed hyperlipidemia in adults. In clinical trials, 2 mg/d reduced total cholesterol and LDLc similar to atorvastatin 10 mg/d and simvastatin 20 mg/d.

How statins bind to and inhibit their target HMG-CoA?

Statins act by competitively binding to the catalytic domain of 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMG-CoA reductase, HMGCR)8,9 and blocking the conversion of HMG-CoA to mevalonate, the rate-limiting step of cholesterol biosynthesis.

What does mevalonate kinase do?

Mevalonate kinase is a metabolic enzyme involved in cholesterol biosynthesis which catalyzes the conversion of mevalonate to phosphomevalonate, the precursor of cholesterol and many natural products.

What is 3 hydroxy 3 methylglutaryl coenzyme A reductase inhibitors?

3-Hydroxy-3-methylglutaryl–coenzyme A (HMG-CoA) reductase inhibitors (statins) are among the most prescribed medications in the United States. Statins act on the rate-limiting step in cholesterol biosynthesis (the conversion of HMG-CoA to mevalonate) and are effective in treating dyslipidemia.

How do you inhibit HMG-CoA reductase?

How do statins block HMG-CoA reductase?

What is Hida syndrome?

Hyperimmunoglobulin D syndrome is a disease that triggers episodes of inflammation in your body. It’s also called hyper-IgD syndrome, or HIDS. It’s a less severe form of a metabolic disorder called mevalonate kinase deficiency (MKD). The condition causes these symptoms: Joint pain.

What causes high IgD?

Growth and development is usually not affected. Hyper IgD syndrome is caused by genetic changes in the MVK gene which provides instructions for making the mevalonate kinase enzyme. The genetic changes result in the partial deficiency of the enzyme.